LongCovid
Excellent article by Shi En Kim published in Chemical & Engineering News on the main challenges of finding treatment for Long COVID. This publication also presents an overview of the treatment…
Do not miss this extraordinary conversation on Long COVID between Dr. Eric Topol (professor, molecular medicine, executive vice-president of Scripps Research, and founder and director of its Scripps Research Translational…
In the frame of the Initiative Long COVID, launched by German Federal Ministry of Health (Bundesministeriums für Gesundheit, BMG), on the 12th of September 2023, patients, representatives of…
The German Federal Ministry of Health (Bundesministeriums für Gesundheit, BMG) launched in July 2023 the initiative Long COVID: Comprehensive support for those affected. The comprehensive Long COVID programme…
The EU-funded BY-COVID project aims to make COVID-19 data accessible to scientists in laboratories but also to anyone who can use it, such as medical staff in hospitals or government…
Why do some people infected with COVID-19 develop postacute sequelae of COVID-19 (PASC) while others do not? This is the question that Herman et al. try to answer with…
Very interesting position paper led by Dr. Amy Proal reviewing studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) samples. “SARS-CoV-2 reservoir may drive inflammatory,…
Do not miss this very interesting article published by The Intelligencer (New York Magazine) about Lisa Sanders, internal-medicine doctor at Yale University School of Medicine, and her job at…
A new prospective cohort study published by Nature Medicine (Nature Portfolio) on Long COVID. From more than 1,800 adults hospitalized with Covid-19, the authors identified two distinct biomarker profiles…
Ziyad Al-Aly, chief of research and development at the Veterans Affairs St. Louis Health Care System and a clinical epidemiologist at Washington University in St. Louis, did recently a…